RBC Capital Reaffirms Their Buy Rating on Moody’s (MCO)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Moody’s (MCO – Research Report) on February 4 and set a price target of $550.00.
RBC cuts Atkore stock price target to $73 from $91
RBC Capital Markets adjusted its outlook on Atkore International Group Inc . (NYSE: NYSE:ATKR), reducing the company's price target from $91.00 to $73.00 while maintaining a Sector Perform rating.
bovnews12h
Why Did RBC Capital Mkts Give SAGE Therapeutics Inc (SAGE) Stock Sector Perform Rating?
RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...
RBC Capital Remains a Buy on S&P Global (SPGI)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on S&P Global (SPGI – Research Report) on February 4 and set a price target of ...
RBC cuts Regeneron stock price target to $1,045, keeps Outperform
RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...
Energy & Utilities Roundup: Market Talk
Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...
Sarepta could be down on patient death in FDA database, says RBC Capital
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
Alphabet playing offense on AI, says RBC Capital
RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...